| 영문 | alpha particles | 한글 | 알파입자 |
|---|---|---|---|
| 설명 | 원자에 정상보다 과다, 과소한 중성자나 양자를 가지고 있는 경우에 원자가 안정되기 위해서 붕괴가 생긴다. 이런 붕괴에는 다음과 같은 3가지 방법이 있다. 알파－붕괴는 알파입자를 방출하여 안정되는 법, 즉 원자번호는 2씩 감소하고 질량수는 4씩 감소한다. 알파입자란 알파붕괴에 의해서 생기는 헬륨의 핵과 같은 입자를 말한다. |
||
| 영문 | alpha-fetoprotein | 한글 | 알파태아단백 |
|---|---|---|---|
| 설명 | 태아의 간조직이나 소화기관에서 만들어지는 단백질. 태아기나 임산부에서 정상적으로 존재한다. 그러나 간암세포나 생식세포에 관련된 종양에서도 만들어져 이런 질병이 존재할 때에는 임산부나 태아가 아니더라도 조직이나 혈액에 나타나게 된다. 임상적으로는 간암이나 생식세포 종양의 발견과 치료효과 판정에 이용되고, 또 임신 16~18주에 산모의 혈액에서 이단백질의 양을 측정하여 태아의 비정상적인 발달을 발견할 수 있다. |
||
| NMB | neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ... |
|---|---|
| SBF | serologic-blocking factor; specific blocking factor; splanchnic blood flow |
| BA | Bachelor of Arts; backache; bacterial agglutination; basilar artery; basion; benzyladenine; best amp... |
| GBA | ganglionic blocking agent; gingivobuccoaxial |
| NMBA | neuromuscular blocking agent |
| NMBA | Neuromuscular blocking agent |
|---|---|
| PIBF | Progesterone Induced Blocking Factor |
| TSBAb | Thyroid stimulation blocking antibodies |
| TSBAb | Thyroid stimulation-blocking antibody |
| BF | blocking factor |
| alpha blocking | The attenuation of the occipital alpha rhythm (8-14 Hz brain waves as seen on an electroencephalogram), produced by opening the eyes or by intense mental concentration. (05 Mar 2000) |
|---|
| alpha-adrenergic blocking agent | An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension. Synonym: alpha-blocker. (05 Mar 2000) |
|---|---|
| adrenergic blocking agent | A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's. (05 Mar 2000) |
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |
| antibodies, blocking | Antibodies that inhibit the reaction between antigen and other antibodies or sensitised T-lymphocytes (e.g., antibodies of the IgG class that compete with IgE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumours and prevent destruction of tumour cells by cytotoxic T-lymphocytes have also been called enhancing antibodies. (12 Dec 1998) |
| beta-adrenergic blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| blocking | 1. Obstructing; arresting of passage, conduction, or transmission. 2. In psychoanalysis, a sudden break in free association occurring when a painful subject or repressed complex is touched. 3. Sudden cessation of thoughts and speech, which may indicate the presence of a severe thought disorder or a psychosis. (05 Mar 2000) |
| blocking activity | The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus. (05 Mar 2000) |
| blocking agent | A class of drugs that inhibit (block) a biologic activity or process, such as axonal conduction or transmission, or ions across a cell membrane; frequently called "blockers." (05 Mar 2000) |
| blocking antibody | An antibody used in a reaction to prevent some other reaction taking place, for example one antibody competing with another for a cell surface receptor. See: desensitisation. (18 Nov 1997) |
| ganglionic blocking agent | An agent that impairs the passage of impulses in autonomic ganglia. (05 Mar 2000) |
| Rh blocking test | A test for nonagglutinating Rh antibodies: an Rh agglutination test is first carried out; if the test for Rh agglutinins is negative, then 1 drop of anti-Rho agglutinating serum of moderate titre is mixed with the patient's serum containing Rh-positive test cells; if after incubating for from 1 to 2 hr at 37캜 no agglutination occurs, Rho-blocking antibodies are assumed to be present in the patient's serum. (05 Mar 2000) |
| slow channel-blocking agent | calcium channel-blocking agent |
| spermatogenesis-blocking agents | Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa. (12 Dec 1998) |
| neuromuscular blocking agent | A group of drugs that prevent motor nerve endings from exciting skeletal muscle. They act either by competing for the neurotransmitter, acetylcholine, (like D-tubocurarine, mivacurium and pancuronium), or by first stimulating the postjunctional muscle membrane and subsequently desensitizing the muscle endplates to the acetylcholine (like succinylcholine or decamethonium); used in surgery to produce paralysis and facilitate manipulation of muscles. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|